A potential COVID-19 vaccine, delivered by microscopic needles, produces antibodies specific to the virus when tested in mice. This is the first peer-reviewed paper describing a COVID-19 vaccine candidate. The next step is a human clinical trial.
from Top Health News -- ScienceDaily https://ift.tt/3aD9wlZ
Post a Comment